Literature DB >> 32196827

Racial disparities in breast cancer hereditary risk assessment referrals.

Jennifer M Peterson1, Abigail Pepin2, Rehema Thomas2, Tara Biagi3, Elizabeth Stark3, Andrew D Sparks4, Kerry Johnson5, Rebecca Kaltman6.   

Abstract

For poorly understood reasons, Black non-Hispanic (BNH) women meeting National Comprehensive Cancer Network (NCCN) criteria for genetic testing for breast cancer risk are less likely than White non-Hispanic (WNH) women to undergo testing (Armstrong, Micco, Carney, Stopfer, & Putt, JAMA, 293, 1729 and 2005). We compared physician referral rates and uptake for genetic testing of BNH and WNH women meeting select NCCN criteria (breast cancer under age 50, two primary breast cancers, triple-negative disease under age 60) in the Cancer Center at George Washington University (GWCC) between 2015 and 2018. Of the 723 BNH and WNH patients treated for breast cancer at GWCC, 28% met study criteria for genetic counseling referral (n = 252; BNH n = 115, WNH n = 137). Physician referral rates to genetic counseling differed significantly by race (BNH 75.7%, n = 87 and WNH 92.7%; n = 127; χ2  = 14.19, p-value < .01). Once referred, though, there was no significant difference in uptake of genetic counseling by race (BNH 95.4%, n = 83; WNH 97.6%, n = 124, χ2  = 1.33, p-value = .25) for patients appropriately referred.
© 2020 National Society of Genetic Counselors.

Entities:  

Keywords:  African-American; Black non-Hispanic; Breast cancer; D.C.; Washington; White Non-Hispanic; attitudes; disparities; genetic counseling; genetic testing; health disparities; hereditary risk assessment; risk management; underrepresented populations

Mesh:

Substances:

Year:  2020        PMID: 32196827     DOI: 10.1002/jgc4.1250

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  10 in total

1.  Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.

Authors:  Allison W Kurian; Paul Abrahamse; Kevin C Ward; Ann S Hamilton; Dennis Deapen; Jonathan S Berek; Lily Hoang; Amal Yussuf; Jill Dolinsky; Krystal Brown; Thomas Slavin; Timothy P Hofer; Steven J Katz
Journal:  JCO Precis Oncol       Date:  2021-12-22

Review 2.  Germline genetics of prostate cancer.

Authors:  Hiba M Khan; Heather H Cheng
Journal:  Prostate       Date:  2022-08       Impact factor: 4.012

3.  A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources.

Authors:  Ken Wiley; Laura Findley; Madison Goldrich; Tejinder K Rakhra-Burris; Ana Stevens; Pamela Williams; Carol J Bult; Rex Chisholm; Patricia Deverka; Geoffrey S Ginsburg; Eric D Green; Gail Jarvik; George A Mensah; Erin Ramos; Mary V Relling; Dan M Roden; Robb Rowley; Gil Alterovitz; Samuel Aronson; Lisa Bastarache; James J Cimino; Erin L Crowgey; Guilherme Del Fiol; Robert R Freimuth; Mark A Hoffman; Janina Jeff; Kevin Johnson; Kensaku Kawamoto; Subha Madhavan; Eneida A Mendonca; Lucila Ohno-Machado; Siddharth Pratap; Casey Overby Taylor; Marylyn D Ritchie; Nephi Walton; Chunhua Weng; Teresa Zayas-Cabán; Teri A Manolio; Marc S Williams
Journal:  J Am Med Inform Assoc       Date:  2022-07-12       Impact factor: 7.942

Review 4.  The role of genomics in global cancer prevention.

Authors:  Ophira Ginsburg; Paul Brennan; Patricia Ashton-Prolla; Anna Cantor; Daniela Mariosa
Journal:  Nat Rev Clin Oncol       Date:  2020-09-24       Impact factor: 66.675

5.  Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system.

Authors:  Kristin R Muessig; Jamilyn M Zepp; Erin Keast; Elizabeth E Shuster; Ana A Reyes; Briana Arnold; Chalinya Ingphakorn; Marian J Gilmore; Tia L Kauffman; Jessica Ezzell Hunter; Sarah Knerr; Heather S Feigelson; Katrina A B Goddard
Journal:  Hered Cancer Clin Pract       Date:  2022-02-10       Impact factor: 2.857

Review 6.  Do current family history-based genetic testing guidelines contribute to breast cancer health inequities?

Authors:  Samantha H Jakuboski; Jasmine A McDonald; Mary Beth Terry
Journal:  NPJ Breast Cancer       Date:  2022-03-22

Review 7.  Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review.

Authors:  Ambreen Khan; Charles R Rogers; Carson D Kennedy; AnaMaria Lopez; Joanne Jeter
Journal:  Oncologist       Date:  2022-04-05

8.  Unusual Association of NF-κB Components in Tumor-Associated Macrophages (TAMs) Promotes HSPG2-Mediated Immune-Escaping Mechanism in Breast Cancer.

Authors:  Veronica De Paolis; Fabio Maiullari; Maila Chirivì; Marika Milan; Chiara Cordiglieri; Francesca Pagano; Alessandra Rita La Manna; Elena De Falco; Claudia Bearzi; Roberto Rizzi; Chiara Parisi
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

Review 9.  Leveraging Electronic Health Records to Address Breast Cancer Disparities.

Authors:  Solange Bayard; Genevieve Fasano; Rulla M Tamimi; Pilyung Stephen Oh
Journal:  Curr Breast Cancer Rep       Date:  2022-09-03

10.  Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.

Authors:  Julie O Culver; Yael Freiberg; Charité Ricker; Jacob G Comeaux; Emmeline Y Chang; Victoria Banerjee; Duveen Sturgeon; Ilana Solomon; Josie Kagey; Mariana G Dobre; Joseph Carey; Azadeh Carr; Stephanie Cho; Janice Lu; Irene M Kang; Ketan Patel; Alicia Terando; Jason C Ye; Ming Li; Caryn Lerman; Darcy Spicer; Maria Nelson
Journal:  Ann Surg Oncol       Date:  2022-09-26       Impact factor: 4.339

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.